 - Recipients who are at least 4 weeks post renal transplantation with stable renal function, Patients currently receiving MMF all dosages are allowed and either cyclosporine USP MODIFIED or tacrolimus with or without corticosteroids as part of their immunosuppressive regimen for at least 2 weeks prior to study start 